These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 21456632)

  • 21. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults.
    Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
    Ther Drug Monit; 2008 Jun; 30(3):320-32. PubMed ID: 18520604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Psychostimulant Khat (Catha edulis) Inhibits CYP2D6 Enzyme Activity in Humans.
    Bedada W; de Andrés F; Engidawork E; Pohanka A; Beck O; Bertilsson L; Llerena A; Aklillu E
    J Clin Psychopharmacol; 2015 Dec; 35(6):694-9. PubMed ID: 26444948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implications of mechanism-based inhibition of CYP2D6 for the pharmacokinetics and toxicity of MDMA.
    Yang J; Jamei M; Heydari A; Yeo KR; de la Torre R; Farré M; Tucker GT; Rostami-Hodjegan A
    J Psychopharmacol; 2006 Nov; 20(6):842-9. PubMed ID: 16714321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of black seed on dextromethorphan O- and N-demethylation in human liver microsomes and healthy human subjects.
    Al-Jenoobi FI; Al-Thukair AA; Abbas FA; Ansari MJ; Alkharfy KM; Al-Mohizea AM; Al-Suwayeh SA; Jamil S
    Drug Metab Lett; 2010 Jan; 4(1):51-5. PubMed ID: 20201775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers.
    Aarnoutse RE; Kleinnijenhuis J; Koopmans PP; Touw DJ; Wieling J; Hekster YA; Burger DM
    Clin Pharmacol Ther; 2005 Dec; 78(6):664-74. PubMed ID: 16338282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to in vitro CYP2D6 and CYP3A4 inhibition study.
    Spanakis M; Vizirianakis IS; Mironidou-Tzouveleki M; Niopas I
    Biomed Chromatogr; 2009 Nov; 23(11):1131-7. PubMed ID: 19444798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CYP2D6 Genotype Phenotype Discordance Due to Drug-Drug Interaction.
    Monte AA; West K; McDaniel KT; Flaten HK; Saben J; Shelton S; Abdelmawla F; Bushman LR; Williamson K; Abbott D; Anderson PL
    Clin Pharmacol Ther; 2018 Nov; 104(5):933-939. PubMed ID: 29882961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects.
    Funck-Brentano C; Boëlle PY; Verstuyft C; Bornert C; Becquemont L; Poirier JM
    Eur J Clin Pharmacol; 2005 Dec; 61(11):821-9. PubMed ID: 16315033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of cytochrome p450 isoenzymes 3A and 2D6 in the in vivo metabolism of mirabegron, a β3-adrenoceptor agonist.
    Lee J; Moy S; Meijer J; Krauwinkel W; Sawamoto T; Kerbusch V; Kowalski D; Roy M; Marion A; Takusagawa S; van Gelderen M; Keirns J
    Clin Drug Investig; 2013 Jun; 33(6):429-40. PubMed ID: 23625188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of mirtazapine metabolism by Ecstasy (MDMA) in isolated perfused rat liver model.
    Jamshidfar S; Ardakani YH; Lavasani H; Rouini M
    Daru; 2017 Jun; 25(1):16. PubMed ID: 28659160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the Differences in the Pharmacokinetics of CYP2D6 Substrates, Desipramine, and Dextromethorphan in Healthy African Subjects Carrying the Allelic Variants CYP2D6*17 and CYP2D6*29, When Compared with Normal Metabolizers.
    Marasanapalle VP; Masimirembwa C; Sivasubramanian R; Sayyed S; Weinzierl-Hinum A; Mehta D; Kapungu NN; Kanji C; Thelingwani R; Zack J
    J Clin Pharmacol; 2024 May; 64(5):578-589. PubMed ID: 37803948
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
    Markowitz JS; Donovan JL; Devane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
    Clin Pharmacol Ther; 2003 Dec; 74(6):536-42. PubMed ID: 14663456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers.
    Markowitz JS; Devane CL; Chavin KD; Taylor RM; Ruan Y; Donovan JL
    Clin Pharmacol Ther; 2003 Aug; 74(2):170-7. PubMed ID: 12891227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers.
    Donovan JL; DeVane CL; Chavin KD; Wang JS; Gibson BB; Gefroh HA; Markowitz JS
    Drug Metab Dispos; 2004 Dec; 32(12):1333-6. PubMed ID: 15328251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of CYP2D6 and CYP2C19 activity in vivo in humans: a cocktail study with dextromethorphan and chloroguanide alone and in combination.
    Tennezé L; Verstuyft C; Becquemont L; Poirier JM; Wilkinson GR; Funck-Brentano C
    Clin Pharmacol Ther; 1999 Dec; 66(6):582-8. PubMed ID: 10613613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative methods for CYP2D6 phenotyping: comparison of dextromethorphan metabolic ratios from AUC, single point plasma, and urine.
    Chen R; Wang H; Shi J; Hu P
    Int J Clin Pharmacol Ther; 2016 May; 54(5):330-6. PubMed ID: 26902503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of cytochrome P450 2D6 phenotyping in healthy adult Western Indians.
    Gogtay NJ; Mali NB; Iyer K; Kadam PP; Sridharan K; Shrimal D; Thatte UM
    Indian J Pharmacol; 2014; 46(3):266-9. PubMed ID: 24987171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytochrome P
    Dhuya M; Pal MM; Hazra A; Chatterjee S; Gogtay N
    Indian J Pharmacol; 2020; 52(3):189-195. PubMed ID: 32874001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers.
    Markowitz JS; Donovan JL; Lindsay DeVane C; Sipkes L; Chavin KD
    J Clin Psychopharmacol; 2003 Dec; 23(6):576-81. PubMed ID: 14624188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-linear pharmacokinetics of MDMA ('ecstasy') in humans.
    de la Torre R; Farré M; Ortuño J; Mas M; Brenneisen R; Roset PN; Segura J; Camí J
    Br J Clin Pharmacol; 2000 Feb; 49(2):104-9. PubMed ID: 10671903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.